Cortical gray matter and cerebral white matter atrophy and asymmetry in Parkinson’s disease patients with normal cognitive precede

References

• Hou Y, Shang H. Magnetic resonance imaging markers for cognitive impairment in Parkinson’s disease: current view. Front Aging Neurosci. 2022;14:788846. doi:10.3389/fnagi.2022.788846.
   PubMed Web of Science ®Google Scholar
• Sarasso E, Agosta F, Piramide N, et al. Progression of grey and white matter brain damage in Parkinson’s disease: a critical review of structural MRI literature. J Neurol. 2021;268(9):3144–3179. doi:10.1007/s00415-020-09863-8.
   PubMed Web of Science ®Google Scholar
• Lewis MM, Du G, Lee E-Y, et al. The pattern of gray matter atrophy in Parkinson’s disease differs in cortical and subcortical regions. J Neurol. 2016;263(1):68–75. doi:10.1007/s00415-015-7929-7.
   PubMed Web of Science ®Google Scholar
• Rai SN, Singh P. Advancement in the modelling and therapeutics of Parkinson’s disease. J Chem Neuroanat. 2020;104:101752. doi:10.1016/j.jchemneu.2020.101752.
   PubMed Web of Science ®Google Scholar
• Ramakrishna K, Nalla LV, Naresh D, et al. WNT-β catenin signaling as a potential therapeutic target for neurodegenerative diseases: current status and future perspective. Diseases. 2023;11(3):89. doi:10.3390/diseases11030089.
   PubMed Web of Science ®Google Scholar
• Rosenberg-Katz K, Herman T, Jacob Y, et al. Gray matter atrophy distinguishes between Parkinson disease motor subtypes. Neurology. 2013;80(16):1476–1484. doi:10.1212/WNL.0b013e31828cfaa4.
   PubMed Web of Science ®Google Scholar
• Campabadal A, Uribe C, Segura B, et al. Brain correlates of progressive olfactory loss in Parkinson’s disease. Parkinsonism Relat Disord. 2017;41:44–50. doi:10.1016/j.parkreldis.2017.05.005.
   PubMed Web of Science ®Google Scholar
• Ibarretxe-Bilbao N, Junque C, Segura B, et al. Progression of cortical thinning in early Parkinson’s disease. Mov Disord. 2012;27(14):1746–1753. doi:10.1002/mds.25240.
   PubMed Web of Science ®Google Scholar
• Jia X, Liang P, Li Y, et al. Longitudinal study of gray matter changes in Parkinson disease. AJNR Am J Neuroradiol. 2015;36(12):2219–2226. doi:10.3174/ajnr.A4447.
   PubMed Web of Science ®Google Scholar
• Sampedro F, Martínez-Horta S, Marín-Lahoz J, et al. Longitudinal intracortical diffusivity changes in de-novo Parkinson’s disease: a promising imaging biomarker. Parkinsonism Relat Disord. 2019;68:22–25. doi:10.1016/j.parkreldis.2019.09.031.
   PubMed Web of Science ®Google Scholar
• Agosta F, Canu E, Stojković T, et al. The topography of brain damage at different stages of Parkinson’s disease. Hum Brain Mapp. 2013;34(11):2798–2807. doi:10.1002/hbm.22101.
   PubMed Web of Science ®Google Scholar
• Filippi M, Sarasso E, Piramide N, et al. Progressive brain atrophy and clinical evolution in Parkinson’s disease. Neuroimage Clin. 2020;28:102374. doi:10.1016/j.nicl.2020.102374.
   PubMed Web of Science ®Google Scholar
• Mak E, Su L, Williams GB, et al. Neuroimaging correlates of cognitive impairment and dementia in Parkinson’s disease. Parkinsonism Relat Disord. 2015;21(8):862–870. doi:10.1016/j.parkreldis.2015.05.013.
   PubMed Web of Science ®Google Scholar
• Claassen DO, McDonell KE, Donahue M, et al. Cortical asymmetry in Parkinson’s disease: early susceptibility of the left hemisphere. Brain Behav. 2016;6(12):e00573. doi:10.1002/brb3.573.
   PubMed Web of Science ®Google Scholar
• Jahanshahi AR, Naghdi Sadeh R, Khezerloo D. Atrophy asymmetry in hippocampal subfields in patients with alzheimer’s disease and mild cognitive impairment. Exp Brain Res. 2023;241(2):495–504. doi:10.1007/s00221-022-06543-z.
   PubMed Web of Science ®Google Scholar
• Zhou C, Guan XJ, Guo T, et al. Progressive brain atrophy in Parkinson’s disease patients who convert to mild cognitive impairment. CNS Neurosci Ther. 2020;26(1):117–125. doi:10.1111/cns.13188.
   PubMed Web of Science ®Google Scholar
• Sarica A, Vasta R, Novellino F, et al. MRI asymmetry index of hippocampal subfields increases through the continuum from the mild cognitive impairment to the Alzheimer’s disease. Front Neurosci. 2018;12:576. doi:10.3389/fnins.2018.00576.
   PubMed Web of Science ®Google Scholar
• Heinrichs-Graham E, Santamaria PM, Gendelman HE, et al. The cortical signature of symptom laterality in Parkinson’s disease. Neuroimage Clin. 2017;14:433–440. doi:10.1016/j.nicl.2017.02.010.
   PubMed Web of Science ®Google Scholar
• Li K, Zhao H, Li C-M, et al. The relationship between side of onset and cerebral regional homogeneity in Parkinson’s disease: a resting-state fMRI study. Parkinson’s Dis. 2020;5146253:1–8. doi:10.1155/2020/5146253
   Web of Science ®Google Scholar
• Lin Z, Zhang C, Li D, et al. Lateralized effects of deep brain stimulation in Parkinson’s disease: evidence and controversies. NPJ Parkinsons Dis. 2021;7(1):64. doi:10.1038/s41531-021-00209-3.
   PubMed Web of Science ®Google Scholar
• Yu F, Barron DS, Tantiwongkosi B, et al. Patterns of gray matter atrophy in atypical Parkinsonism syndromes: a VBM meta-analysis. Brain Behav. 2015;5(6):e00329. doi:10.1002/brb3.329.
   PubMed Web of Science ®Google Scholar
• Hattori T, Orimo S, Aoki S, et al. Cognitive status correlates with white matter alteration in Parkinson’s disease. Hum Brain Mapp. 2012;33(3):727–739. doi:10.1002/hbm.21245.
   PubMed Web of Science ®Google Scholar
• Melzer TR, Watts R, MacAskill MR, et al. White matter microstructure deteriorates across cognitive stages in Parkinson disease. Neurology. 2013;80(20):1841–1849. doi:10.1212/WNL.0b013e3182929f62.
   PubMed Web of Science ®Google Scholar
• Rektor I, Svátková A, Vojtíšek L, et al. White matter alterations in Parkinson’s disease with normal cognition precede grey matter atrophy. PloS One. 2018;13(1):e0187939. doi:10.1371/journal.pone.0187939.
   PubMed Web of Science ®Google Scholar
• Auning E, Kjærvik VK, Selnes P, et al. White matter integrity and cognition in Parkinson’s disease: a cross-sectional study. BMJ Open,. 2014;4(1):e003976. doi:10.1136/bmjopen-2013-003976.
   PubMed Web of Science ®Google Scholar
• Duncan GW, Firbank MJ, Yarnall AJ, et al. Gray and white matter imaging: a biomarker for cognitive impairment in early P arkinson’s disease? Mov Disord. 2016;31(1):103–110. doi:10.1002/mds.26312.
   PubMed Web of Science ®Google Scholar
• Theilmann RJ, Reed JD, Song DD, et al. White-matter changes correlate with cognitive functioning in Parkinson’s disease. Front Neurol. 2013;4:37. doi:10.3389/fneur.2013.00037.
   PubMed Web of Science ®Google Scholar
• Sterling NW, Du G, Lewis MM, et al. Cortical gray and subcortical white matter associations in Parkinson’s disease. Neurobiol Aging. 2017;49:100–108. doi:10.1016/j.neurobiolaging.2016.09.015.
   PubMed Web of Science ®Google Scholar
• Tessa C, Lucetti C, Giannelli M, et al. Progression of brain atrophy in the early stages of Parkinson’s disease: a longitudinal tensor-based morphometry study in de novo patients without cognitive impairment. Hum Brain Mapp. 2014;35(8):3932–3944. doi:10.1002/hbm.22449.
   PubMed Web of Science ®Google Scholar
• Nürnberger L, Gracien R-M, Hok P, et al. Longitudinal changes of cortical microstructure in Parkinson’s disease assessed with T1 relaxometry. Neuroimage Clin. 2017;13:405–414. doi:10.1016/j.nicl.2016.12.025.
   PubMed Web of Science ®Google Scholar
• Serrien DJ, Ivry RB, Swinnen SP. Dynamics of hemispheric specialization and integration in the context of motor control. Nat Rev Neurosci. 2006;7(2):160–166. doi:10.1038/nrn1849.
   PubMed Web of Science ®Google Scholar
• Serrien DJ, Sovijärvi-Spapé MM. Hemispheric asymmetries and the control of motor sequences. Behav Brain Res. 2015;283:30–36. doi:10.1016/j.bbr.2015.01.021.
   PubMed Web of Science ®Google Scholar
• Caminiti SP, Presotto L, Baroncini D, et al. Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson’s disease. Neuroimage Clin. 2017;14:734–740. doi:10.1016/j.nicl.2017.03.011.
   PubMed Web of Science ®Google Scholar